Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

NCT06986018 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Inflammatory Myopathies
ANCA-Associated Vasculitis

Interventions

DRUG: RD06-04 Cell Injection Infusion

Sponsor

Peking University People's Hospital